Chapter 7: Over-the-Counter Drugs and Herbal and Dietary Supplements

With hundreds of thousands of OTC products available to consumers without prescription, the chapter emphasizes both the considerable benefits and significant risks associated with self-care medication practices. Key advantages include increased accessibility, reduced healthcare costs, and patient autonomy in managing minor health concerns, yet these benefits are counterbalanced by substantial hazards such as product misuse, toxicity, adverse drug interactions, and the potential for delayed professional medical intervention when symptoms warrant clinical evaluation. The regulatory environment governing these products is central to the chapter's framework, encompassing the FDA's OTC Drug Review process, which establishes safety and efficacy standards, and the Dietary Supplement Health and Education Act (DSHEA), which provides a distinct regulatory pathway for supplements with different labeling requirements and oversight mechanisms. The chapter critically evaluates herbal medicine traditions across cultures, investigating the active phytochemical constituents responsible for therapeutic effects while addressing quality inconsistency issues and safety concerns specific to commonly used remedies. Notable examples include kava's hepatotoxic potential, ephedra's cardiovascular risks, and the interaction profiles of St. John's wort, ginseng, ginkgo, garlic, echinacea, and valerian. A fundamental nursing principle presented throughout is that natural origin does not guarantee safety or efficacy. The nursing process framework guides comprehensive patient assessment of OTC and herbal product use, evidence-based patient education regarding potential drug-drug and drug-food interactions, medication monitoring, and coordinated care planning that integrates alternative therapies safely with conventional pharmacological treatments while promoting informed decision-making and therapeutic safety.